| Literature DB >> 26301484 |
Ronan E O'Carroll1, Julie A Chambers2, Linda Brownlee3, Gillian Libby4, Robert J C Steele5.
Abstract
Screening is important for early detection of colorectal cancer. Our aim was to determine whether a simple anticipated regret (AR) intervention could increase uptake of colorectal cancer screening. A randomised controlled trial of a simple, questionnaire-based AR intervention, delivered alongside existing pre-notification letters, was conducted. A total of 60,000 adults aged 50-74 years from the Scottish National Screening programme were randomised into the following groups: (1) no questionnaire (control), (2) Health Locus of Control questionnaire (HLOC) or (3) HLOC plus AR questionnaire. The primary outcome was return of the guaiac faecal occult blood test (FOBT). The secondary outcomes included intention to return test kit and perceived disgust (ICK). A total of 59,366 people were analysed as allocated (intention-to-treat (ITT)); no overall differences were seen between the treatment groups on FOBT uptake (control: 57.3%, HLOC: 56.9%, AR: 57.4%). In total, 13,645 (34.2%) individuals returned the questionnaires. Analysis of the secondary questionnaire measures showed that AR indirectly affected FOBT uptake via intention, whilst ICK directly affected FOBT uptake over and above intention. The effect of AR on FOBT uptake was also moderated by intention strength: for less-than-strong intenders only, uptake was 4.2% higher in the AR (84.6%) versus the HLOC group (80.4%) (95% CI for difference (2.0, 6.5)). The findings show that psychological concepts including AR and perceived disgust (ICK) are important factors in determining FOBT uptake. However, the AR intervention had no simple effect in the ITT analysis. It can be concluded that, in those with low intentions, exposure to AR may be required to increase FOBT uptake. The current controlled trials are presented at the website www.controlled-trials.com (number: ISRCTN74986452).Entities:
Keywords: Anticipated regret; Colorectal cancer; Disgust; Faecal occult blood test; Screening
Mesh:
Year: 2015 PMID: 26301484 PMCID: PMC4576211 DOI: 10.1016/j.socscimed.2015.07.026
Source DB: PubMed Journal: Soc Sci Med ISSN: 0277-9536 Impact factor: 4.634
Fig. 1CONSORT diagram.
Logistic regression of FOBT uptake by treatment group unadjusted and adjusted for demographics and history of returning kits.
| Unadjusted odds ratio (95% CI) | ||
|---|---|---|
| Control | – | – |
| HLOC | 0.98 (0.94, 1.02) | 0.97 (0.91, 1.01) |
| AR | 1.00 (0.97, 1.05) | 1.00 (0.95, 1.06) |
| Male | – | – |
| Female | 1.24 (1.20, 1.28) | 1.03 (0.98, 1.07) |
| 50–54 years | – | – |
| 55–59 years | 1.33 (1.27, 1.39) | 1.14 (1.06, 1.23) |
| 60–65 years | 1.62 (1.54, 1.71) | 1.34 (1.23, 1.45) |
| 66–69 years | 1.95 (1.85, 2.04) | 1.41 (1.31, 1.53) |
| 70–74 years | 1.68 (1.59, 1.77) | 0.99 (0.91, 1.07) |
| 1 (Most deprived) | – | – |
| 2 | 1.36 (1.29, 1.44) | 1.21 (1.12, 1.30) |
| 3 | 1.68 (1.59, 1.77) | 1.36 (1.27, 1.46) |
| 4 | 2.09 (1.98, 2.20) | 1.57 (1.46, 1.69) |
| 5 (Least deprived) | 2.30 (2.18, 2.43) | 1.66 (1.55, 1.80) |
| 7.97 (7.72, 8.22) | 4.15 (3.97, 4.33) | |
| 0.16 (0.16, 0.17) | 0.35 (0.33, 0.36) |
Adjusted for all other variables in the regression. Treatment group in both analyses and gender and 70–74 age band in the adjusted analysis are not considered significant (i.e., CI includes the value 1.0). FOBT = faecal occult blood test; AR = anticipated regret; HLOC = Health Locus of Control; SIMD = Scottish Index of Multiple Deprivation.
Mean (SD) by treatment group and first-order correlations of outcome measures.
| AR | HLOC | All | Spearman's | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6692 | 6953 | 13,645 | 6692 | 13,645 | |||||||
| AR | INT | ICK | PB | HI | HC | HO | |||||
| AR | 6.19 (1.01) | – | – | ||||||||
| Intention (INT) | 6.62 (0.71) | 6.68 (0.72) | 6.65 (0.72) | 0.06 (0.04, 0.09) | 0.62 | ||||||
| ICK | 3.08 (1.47) | 3.06 (1.51) | 3.07 (1.49) | −0.02 (−0.07, 0.03) | −0.21 | −0.24 | |||||
| Perceived benefit (PB) | 6.47 (0.69) | 6.53 (0.69) | 6.50 (0.69) | 0.06 (0.04, 0.08) | 0.57 | 0.54 | −0.21 | ||||
| HLOC Internal (HI) | 4.91 (0.87) | 4.94 (0.86) | 4.93 (0.87) | 0.04 (0.01, 0.06) | 0.19 | 0.14 | −0.08 | 0.25 | |||
| HLOC Chance (HC) | 3.43 (1.07) | 3.41 (1.09) | 3.42 (1.08) | −0.02 (−0.06, 0.02) | −0.03 | −0.08 | 0.17 | −0.06 | −0.04 | ||
| HLOC Others (HO) | 3.91 (1.14) | 3.88 (1.17) | 3.89 (1.15) | −0.02 (−0.06, 0.02) | 0.14 | 0.01 | 0.02 | 0.16 | 0.24 | 0.34 | |
| – | – | – | – | 0.30 | 0.37 | −0.28 | 0.21 | 0.00 | −0.07 | −0.02 | |
Rank biserial correlation coefficient: 0.20 is considered the smallest effect for ‘practical significance’, 0.50 a moderate effect and 0.80 a large effect, according to recent studies (Ferguson, 2009); AR = anticipated regret; ICK = perceived disgust; HLOC = Health Locus of Control; FOBT = faecal occult blood test.
Direct and indirect (via intention) effects of the secondary outcome variables on FOBT uptake.
| Direct effect | Indirect effects | |||||
|---|---|---|---|---|---|---|
| Point estimate | Product of coefficients | 95% CI | ||||
| SE | Lower | Upper | ||||
| ICK | −0.37 | −0.07 | 0.01 | −13.27 | −0.09 | −0.06 |
| Perceived benefit | 0.01 | 0.26 | 0.02 | 18.97 | 0.23 | 0.29 |
| HLOC Internal | −0.10 | 0.01 | 0.00 | 3.22 | 0.005 | 0.02 |
| HLOC Chance | −0.02 | 0.00 | 0.00 | −0.42 | −0.01 | 0.01 |
| HLOC Others | −0.07 | −0.02 | 0.01 | −3.37 | −0.03 | −0.01 |
| AR | 0.15 | 0.23 | 0.02 | 10.91 | 0.19 | 0.28 |
| ICK | −0.31 | −0.04 | 0.01 | −6.85 | −0.06 | −0.03 |
| PB | −0.06 | 0.14 | 0.02 | 10.28 | 0.11 | 0.18 |
| HLOC Internal | 0.09 | 0.00 | 0.01 | 0.22 | −0.01 | 0.01 |
| HLOC Chance | −0.02 | −0.01 | 0.01 | −1.02 | −0.02 | 0.01 |
| HLOC Others | −0.09 | −0.02 | 0.01 | −3.68 | −0.03 | −0.01 |
Note: Based on 5000 bootstrapping samples; 95% CI = lower and upper level of the bias-corrected confidence intervals for α = 0.05: intervals are significant if they do not contain zero (Preacher and Hayes, 2004). Direct effects (including 95% CIs) are also shown in Fig. 2. FOBT = faecal occult blood test; AR = anticipated regret; ICK = perceived disgust; HLOC = Health Locus of Control.
Fig. 2Direct and indirect effects of secondary outcome variables via intentions on FOBT uptake: for both questionnaire groups (top: N = 13,645) and AR group only (bottom: N = 6692).
Bootstrapped indirect effects of AR via intention strength on FOBT uptake.
| Intentions | Point estimate | SE | 95% CI for point estimate | |||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Less than strong | 0.41 | 0.04 | 9.34 | 0.33 | 0.50 | 1.51 (1.39, 1.65) |
| Strong | 0.04 | 0.09 | 0.39 | −0.15 | 0.22 | 1.04 (0.86, 1.25) |
Note: Based on 5000 bootstrapping samples; 95% CI = lower and upper level of the bias-corrected confidence interval for α = 0.05.
The estimated increase in odds of FOBT uptake for each one-standard deviation increase in AR score, evaluated at lower and high intention. AR = anticipated regret; FOBT = faecal occult blood test.
Fig. 3Indirect effect of anticipated regret (AR) on faecal occult blood test (FOBT) uptake at levels of intention strength evaluated at one SD below AR mean, AR mean and 1 SD above AR mean.